UK-based sustainability and climate leaders who are driving business to positive action and solving the planet’s greatest ...
A pioneering — and customizable — program that builds on six decades of innovation, empowering leaders to accelerate their ...
This episode focuses on the strategies for assessing non-small cell lung cancer (NSCLC) therapies that have received FDA accelerated approval. The discussion explains that acceler ...
Thank you, Matt, and thank you all for joining us this morning on our fourth quarter 2025 earnings call. From an earnings ...
EBITDA up 19.9% to $296.5mn, boosted by efficient workforce planning, stronger procurement discipline, tighter overhead ...
In 2025, we delivered another year of double-digit growth, including 11% for adjusted EBITDA and 12% for adjusted earnings ...
This episode examines the barriers to accessing HER2-targeted therapies for non-small cell lung cancer (NSCLC) and strategies ...
Groundbreaking initiative establishes a standard for responsible patient-facing AICLAYMONT, Del., Feb. 11, 2026 /PRNewswire/ ...
A scenario based framework showing how banks can build a sustainable finance strategy that balances long term sustainability commitments with strong financial performance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results